ER Lipid Defects in Neuropeptidergic Neurons Impair Sleep Patterns in Parkinson's Disease

Jorge S. Valadas, Giovanni Esposito, Dirk Vandekerkhove, Katarzyna Miskiewicz, Liesbeth Deaulmerie, Susanna Raitano, Philip Seibler, Christine Klein, Patrik Verstreken*

*Corresponding author for this work

Abstract

Parkinson's disease patients report disturbed sleep patterns long before motor dysfunction. Here, in parkin and pink1 models, we identify circadian rhythm and sleep pattern defects and map these to specific neuropeptidergic neurons in fly models and in hypothalamic neurons differentiated from patient induced pluripotent stem cells (iPSCs). Parkin and Pink1 control the clearance of mitochondria by protein ubiquitination. Although we do not observe major defects in mitochondria of mutant neuropeptidergic neurons, we do find an excess of endoplasmic reticulum-mitochondrial contacts. These excessive contact sites cause abnormal lipid trafficking that depletes phosphatidylserine from the endoplasmic reticulum (ER) and disrupts the production of neuropeptide-containing vesicles. Feeding mutant animals phosphatidylserine rescues neuropeptidergic vesicle production and acutely restores normal sleep patterns in mutant animals. Hence, sleep patterns and circadian disturbances in Parkinson's disease models are explained by excessive ER-mitochondrial contacts, and blocking their formation or increasing phosphatidylserine levels rescues the defects in vivo. Valadas et al. show that ER lipid imbalance causes sleep pattern defects in Parkinson's disease by preventing the formation of secretory vesicles required for the release of the neuropeptides. Restoring the ER lipid balance by supplementation with phosphatidylserine rescues the cellular and behavioral defects.

Original languageEnglish
JournalNeuron
Volume98
Issue number6
Pages (from-to)1155-1169
Number of pages15
ISSN0896-6273
DOIs
Publication statusPublished - 27.06.2018

Funding

We thank the Bloomington, Harvard, and Kyoto Drosophila stock centers and the Developmental Studies Hybridoma bank as well as Bart De Strooper, Patrick Callaerts, Sha Liu, Edwin S. Levitan, Wim Vandenberghe, and Rose Goodchild for reagents. We thank Bart De Strooper, Sha Liu, Wim Vandenberghe, Georg Halder, Vanessa A. Morais, Rose Goodchild, Joseph McInnes, Sabine Kuenen, António Laranjeira, Elsa Lauwers, Ana Rita Santos, the VIB BioImaging core facility, and all members of the Verstreken lab for discussions and help. This work was supported by an ERC Consolidator Grant ( 646671 ), the FWO Vlaanderen , the Hercules Foundation , IWT , BELSPO-IAP , a Methusalem grant of the Flemish government , Opening the Future , the Vlaamse Parkinsonliga , and VIB . J.S.V. is supported by the Fundação para a Ciência e a Tecnologia (FCT , grant number SFRH/BD/88363/2012 ), D.V. is supported by the FWO Vlaanderen , and P.V. is a member of the FENS Kavli Network of Excellence .

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Research Area: Medical Genetics

Fingerprint

Dive into the research topics of 'ER Lipid Defects in Neuropeptidergic Neurons Impair Sleep Patterns in Parkinson's Disease'. Together they form a unique fingerprint.

Cite this